Clinical and economic outcomes of preterm labor management: Inpatient vs outpatient

Journal of Perinatology

Volumn 24, Issue 8, 2004, Pages 515-519

  Ambrose, Steven ^a   Rhea, Debbie J ^b   Istwan, Niki B ^b   Collins, Ann ^b   Stanziano, Gary ^b  

^a ADVOCATE CHRIST MEDICAL CENTER   (United States)

^b Matria Healthcare ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INDOMETACIN; MAGNESIUM DERIVATIVE; NIFEDIPINE; TERBUTALINE; UTERUS SPASMOLYTIC AGENT;

ADULT; ARTICLE; BIRTH RATE; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; DELIVERY; ECONOMIC EVALUATION; FEMALE; FOLLOW UP; GESTATIONAL AGE; HOSPITAL COST; HOSPITAL DISCHARGE; HOSPITAL PATIENT; HUMAN; LOW DRUG DOSE; MAJOR CLINICAL STUDY; OUTPATIENT CARE; PREGNANCY; PREMATURE LABOR; TOCOLYSIS; TREATMENT OUTCOME; UTERINE CERVIX DILATATION;

ADULT; AMBULATORY CARE; DRUG ADMINISTRATION SCHEDULE; FEMALE; GEORGIA; GESTATIONAL AGE; HOSPITAL COSTS; HOSPITALIZATION; HUMANS; INFANT, NEWBORN; INJECTIONS, SUBCUTANEOUS; OBSTETRIC LABOR, PREMATURE; OUTCOME ASSESSMENT (HEALTH CARE); PERINATAL CARE; PREGNANCY; TERBUTALINE; TOCOLYTIC AGENTS;

EID: 4344575859     PISSN: 07438346     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.jp.7211139     Document Type: Article

References (24)

1. Haas JS, Berman S, Goldberg AB, Lee LWK, Cook EF. Prenatal hospitalization and compliance with guidelines for prenatal care. Am J Public Health 1996;86:815-9.
2. Adams MM, Harlass FE, Sarno AP, Read JA, Rawlings JS. Antenatal hospitalization among enlisted servicewomen, 1987-1990. Obstet Gynecol 1994;84:35-9.
3. Gazmararian JA, Petersen R, Jamieson DJ, et al. Hospitalizations during pregnancy among managed care enrollees. Obstet Gynecol 2002;100:94-100.
4. Franks AL, Kendrick JS, Olson DR, Atrash HK, Saftlas AF, Moien M. Hospitalization for pregnancy complications, United States, 1986 and 1987. Am J Obstet Gynecol 1992;166:1339-44.
5. Bennett TA, Kotelchuck M, Cox CE, Tucker MJ, Nadeau DA. Pregnancy-associated hospitalizations in the United States in 1991 and 1992: a comprehensive view of maternal morbidity. Am J Obstet Gynecol 1998;178:346-54.
6. Nicholson WK, Frick KD, Powe NR. Economic burden of hospitalizations for preterm labor in the United States. Obstet Gynecol 2000;96:95-101.
7. Katz VL, Farmer RM. Controversies in tocolytic therapy. Clin Obstet Gynecol 1999;42:802-19.
8. Lam F, Gill PJ, Smith M, Kitzmiller JL, Katz M. Use of subcutaneous terbutaline pump for long term tocolysis. Obstet Gynecol 1988;72:810-3.
9. Moise Jr. KJ, Sala DJ, Zurawin RK, Cano LE, Hesketh DE, Carpenter RJ. Continuous subcutaneous terbutaline pump for premature labor: safety and efficacy. S Med J 1992;85:255-60.
10. Allbert JR, Wise CA, Lou CH, Gookin KS, Parmenter MA, Morrison JC. Subcutaneous tocolytic infusion therapy for patients at high risk for preterm birth. J Perinatol 1992;12:28-31.
11. Adkins RT, Van Hooydonk JE, Bressman PL, et al. Prevention of preterm birth: early detection and aggressive treatment with terbutaline. S Med J 1993;86:157-64.
12. Allbert JR, Johnson C, Roberts WE, Martin RW, Gookin KS, Morrison JC. Tocolysis for recurrent preterm labor using a continuous subcutaneous infusion pump. J Reprod Med 1994;39:614-8.
13. Elliott JP, Flynn MJ, Kaemmerer EL, Radin TG. Terbutaline pump tocolysis in high-order multiple gestation. J Reprod Med 1997;42:687-94.
14. Wenstrom KD, Weiner CP, Merrill D, Neibyl J. A placebo-controlled randomized trial of the terbutaline pump for prevention of preterm delivery. J Perinatol 1997;14:87-91.
15. Lam F, Bergauer NK, Stanziano GJ, Jacques DL. Pregnancy prolongation and route of tocolytic administration in patients with singleton gestation. Am J Obstet Gynecol 1998;178:180.
16. Guinn DA, Goepfert AR, Owen J, Wenstrom KD, Hauth JC. Terbutaline pump maintenance therapy for prevention of preterm delivery: a double blind trial. Am J Obstet Gynecol 1998;179:874-8.
17. Lam F, Bergauer NK, Coleman SK, Stanziano GJ, Jacques DL. A comparison of gestational days gained with oral terbutaline versus continuous subcutaneous terbutaline in women with twin gestations. J Perinatol 2000;20:408-13.
18. Elliott JP, Bergauer NK, Jacques DL, Coleman SK, Stanziano GJ. Pregnancy prolongation in triplet pregnancies. Oral vs. continuous subcutaneous terbutaline. J Reprod Med 2001;46:975-82.
19. Lam F, Bergauer NK, Jacques D, Coleman SK, Stanziano GJ. Clinical and cost-effectiveness of continuous subcutaneous terbutaline versus oral tocolytics for treatment of recurrent preterm labor in twin gestations. J Perinatol 2001;21:444-50.
20. Lam F, Istwan NB, Jacques D, Coleman SK, Stanziano GJ. Managing perinatal outcomes: the clinical benefit and cost-effectiveness of pharmacologic treatment of recurrent preterm labor. Manag Care 2003;12:39-46.
21. Morrison JC, Chauhan SP, Carroll CS, Bofill JA, Magann EF. Continuous subcutaneous terbutaline administration prolongs pregnancy after recurrent preterm labor. Am J Obstet Gynecol 2003;188:1460-7.
22. Goulet C, Gevry H, Lemay M, et al. A randomized clinical trial of care for women with preterm labour: home management versus hospital management. CMAJ 2001;164:985-91.
23. Hartikainen-Sorri AL, Jouppila P. Is routine hospitalization needed in antenatal care of twin pregnancy? J Perinat Med 1984;12:31-4.
24. Saunders MC, Dick JS, Brown IM, McPherson K, Chalmers I. The effects of hospital admission for bed rest on the duration of twin pregnancy: a randomized trial. Lancet 1985, 2(8459):793-5.